nervous system
• decrease in the number of Plp1+ mature oligodendrocytes from P0 to P15
|
• in the white matter of the spinal cord at P15
|
• decrease in the number of Plp1+ mature oligodendrocytes from P0 to P15
• treatment with a T3 analog (GC-1) but not with T4, stimulates oligodendrocyte differentiation
|
homeostasis/metabolism
• increased T4 levels in brain and spinal cord lysates
|
• decreased T3 levels in brain and spinal cord lysates
|
behavior/neurological